What is BRVE's current stock price?

BRVE (Braveheart Bio, Inc.) is currently trading at $30.29 with a market cap of $2.14B.

What sector is Braveheart Bio, Inc. in?

Braveheart Bio, Inc. (BRVE) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

BRVE Braveheart Bio, Inc.

NASDAQHealthcare

$30.29+68.28%ClosedMarket Cap: $2.14B

As of 2026-08-06

Why BRVE matters now

Braveheart Bio, Inc. (BRVE) is a US stock in Healthcare. The latest InvestLog snapshot shows $30.29 with +68.28% on the session and $2.14B in market capitalization.

The latest indexable market news headline is "Braveheart Bio Announces Pricing of Upsized Initial Public Offering" from GlobeNewsWire.

Latest News

Braveheart Bio Announces Pricing of Upsized Initial Public OfferingGlobeNewsWire · 2026-08-05

Braveheart Bio Readies $300 Million IPO PlanSeeking Alpha · 2026-07-31

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor. The company was founded on May 13,2024 and is headquartered in San Francisco, CA.